Valeo Financial Advisors »

Aclaris Therapeutics shares owned by Valeo Financial Advisors

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Valeo Financial Advisors from 13F filings

Historical chart of Valeo Financial Advisors investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Valeo Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Valeo Financial Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $83k 28k 3.01

More positions owned by Valeo Financial Advisors

Spdr S&p 500 Etf Etf (SPY)
Ishares S&p Smallcap 600 Etf Etf (IJR)
Ishares Core S&p Mid Cap Etf Etf (IJH)
Ishares Core Msci Emerging Mkts Etf (IEMG)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Eli Lilly & Co Stock (LLY)
Jpmorgan Core Plus Bond Etf Etf (JCPB)
Invesco S&p 500 Equal Weight Etf Etf (RSP)
Nvidia Corp Stock (NVDA)
Prologis Share Beneficial Int Reit (PLD)
Vanguard Intermediate-term Treasury Etf Etf (VGIT)
Microsoft Stock (MSFT)
Fidelity Total Bond Etf Etf (FBND)
Google Stock (GOOGL)

View all positions for Valeo Financial Advisors

Top funds holding Aclaris Therapeutics

BML Capital Management
Vivo Capital
BlackRock
Vanguard Group
Adage Capital Partners GP
Rock Springs Capital Management
Decheng Capital
Geode Capital Management
D. E. Shaw & Co
Acadian Asset Management
Palo Alto Investors
Millennium Management
State Street Corporation
Connor, Clark & Lunn Investment Management
Citadel Advisors

View all funds holding Aclaris Therapeutics